NGS Analysis Confirms Common <i>TP53</i> and <i>RB1</i> Mutations, and Suggests <i>MYC</i> Amplification in Ocular Adnexal Sebaceous Carcinomas

Ocular adnexal (OA) sebaceous carcinomas generally demonstrate more aggressive clinical and histopathological phenotypes than extraocular cases, but the molecular drivers implicated in their oncogenesis remain poorly defined. A retrospective review of surgical and ocular pathology archives identifie...

Full description

Bibliographic Details
Main Authors: Cornelia Peterson, Robert Moore, Jessica L. Hicks, Laura A. Morsberger, Angelo M. De Marzo, Ying Zou, Charles G. Eberhart, Ashley A. Campbell
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/16/8454
_version_ 1797523662606172160
author Cornelia Peterson
Robert Moore
Jessica L. Hicks
Laura A. Morsberger
Angelo M. De Marzo
Ying Zou
Charles G. Eberhart
Ashley A. Campbell
author_facet Cornelia Peterson
Robert Moore
Jessica L. Hicks
Laura A. Morsberger
Angelo M. De Marzo
Ying Zou
Charles G. Eberhart
Ashley A. Campbell
author_sort Cornelia Peterson
collection DOAJ
description Ocular adnexal (OA) sebaceous carcinomas generally demonstrate more aggressive clinical and histopathological phenotypes than extraocular cases, but the molecular drivers implicated in their oncogenesis remain poorly defined. A retrospective review of surgical and ocular pathology archives identified eleven primary resection specimens of OA sebaceous carcinomas with adequate tissue for molecular analysis; two extraocular cases were also examined. Next-generation sequencing was used to evaluate mutations and copy number changes in a large panel of cancer-associated genes. Fluorescence in situ hybridization (FISH) confirmed <i>MYC</i> copy number gain in select cases, and immunohistochemistry to evaluate MYC protein expression. The commonest mutations occurred in <i>TP53</i> (10/13) and <i>RB1</i> (7/13). Additional mutations in clinically actionable genes, or mutations with a frequency of at least 25%, included the <i>NF1</i> (3/12), <i>PMS2</i> (4/12), <i>ROS1</i> (3/12), <i>KMT2C</i> (4/12), <i>MNX1</i> (6/12), <i>NOTCH1</i> (4/12), <i>PCLO</i> (3/12), and <i>PTPRT</i> (3/12) loci. Low level copy number gain suggestive of amplification of the <i>MYC</i> locus was seen in two cases, and confirmed using FISH. MYC protein expression, as assessed by immunohistochemistry, was present in almost all sebaceous carcinoma cases. Our findings support the concept that alterations in <i>TP53</i> and <i>RB1</i> are the commonest alterations in sebaceous carcinoma, and suggest that <i>MYC</i> may contribute to the oncogenesis of these tumors.
first_indexed 2024-03-10T08:46:13Z
format Article
id doaj.art-c0f0d587b7794b68b19c6d4dea9f114c
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T08:46:13Z
publishDate 2021-08-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-c0f0d587b7794b68b19c6d4dea9f114c2023-11-22T07:55:22ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-08-012216845410.3390/ijms22168454NGS Analysis Confirms Common <i>TP53</i> and <i>RB1</i> Mutations, and Suggests <i>MYC</i> Amplification in Ocular Adnexal Sebaceous CarcinomasCornelia Peterson0Robert Moore1Jessica L. Hicks2Laura A. Morsberger3Angelo M. De Marzo4Ying Zou5Charles G. Eberhart6Ashley A. Campbell7Department of Molecular and Comparative Pathobiology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USADepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USADepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USADepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USADepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USADepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USADepartment of Pathology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USADepartment of Ophthalmology, The Johns Hopkins University School of Medicine, Baltimore, MD 21205, USAOcular adnexal (OA) sebaceous carcinomas generally demonstrate more aggressive clinical and histopathological phenotypes than extraocular cases, but the molecular drivers implicated in their oncogenesis remain poorly defined. A retrospective review of surgical and ocular pathology archives identified eleven primary resection specimens of OA sebaceous carcinomas with adequate tissue for molecular analysis; two extraocular cases were also examined. Next-generation sequencing was used to evaluate mutations and copy number changes in a large panel of cancer-associated genes. Fluorescence in situ hybridization (FISH) confirmed <i>MYC</i> copy number gain in select cases, and immunohistochemistry to evaluate MYC protein expression. The commonest mutations occurred in <i>TP53</i> (10/13) and <i>RB1</i> (7/13). Additional mutations in clinically actionable genes, or mutations with a frequency of at least 25%, included the <i>NF1</i> (3/12), <i>PMS2</i> (4/12), <i>ROS1</i> (3/12), <i>KMT2C</i> (4/12), <i>MNX1</i> (6/12), <i>NOTCH1</i> (4/12), <i>PCLO</i> (3/12), and <i>PTPRT</i> (3/12) loci. Low level copy number gain suggestive of amplification of the <i>MYC</i> locus was seen in two cases, and confirmed using FISH. MYC protein expression, as assessed by immunohistochemistry, was present in almost all sebaceous carcinoma cases. Our findings support the concept that alterations in <i>TP53</i> and <i>RB1</i> are the commonest alterations in sebaceous carcinoma, and suggest that <i>MYC</i> may contribute to the oncogenesis of these tumors.https://www.mdpi.com/1422-0067/22/16/8454sebaceous carcinomaocular adnexal tumornext-generation sequencingMYC
spellingShingle Cornelia Peterson
Robert Moore
Jessica L. Hicks
Laura A. Morsberger
Angelo M. De Marzo
Ying Zou
Charles G. Eberhart
Ashley A. Campbell
NGS Analysis Confirms Common <i>TP53</i> and <i>RB1</i> Mutations, and Suggests <i>MYC</i> Amplification in Ocular Adnexal Sebaceous Carcinomas
International Journal of Molecular Sciences
sebaceous carcinoma
ocular adnexal tumor
next-generation sequencing
MYC
title NGS Analysis Confirms Common <i>TP53</i> and <i>RB1</i> Mutations, and Suggests <i>MYC</i> Amplification in Ocular Adnexal Sebaceous Carcinomas
title_full NGS Analysis Confirms Common <i>TP53</i> and <i>RB1</i> Mutations, and Suggests <i>MYC</i> Amplification in Ocular Adnexal Sebaceous Carcinomas
title_fullStr NGS Analysis Confirms Common <i>TP53</i> and <i>RB1</i> Mutations, and Suggests <i>MYC</i> Amplification in Ocular Adnexal Sebaceous Carcinomas
title_full_unstemmed NGS Analysis Confirms Common <i>TP53</i> and <i>RB1</i> Mutations, and Suggests <i>MYC</i> Amplification in Ocular Adnexal Sebaceous Carcinomas
title_short NGS Analysis Confirms Common <i>TP53</i> and <i>RB1</i> Mutations, and Suggests <i>MYC</i> Amplification in Ocular Adnexal Sebaceous Carcinomas
title_sort ngs analysis confirms common i tp53 i and i rb1 i mutations and suggests i myc i amplification in ocular adnexal sebaceous carcinomas
topic sebaceous carcinoma
ocular adnexal tumor
next-generation sequencing
MYC
url https://www.mdpi.com/1422-0067/22/16/8454
work_keys_str_mv AT corneliapeterson ngsanalysisconfirmscommonitp53iandirb1imutationsandsuggestsimyciamplificationinocularadnexalsebaceouscarcinomas
AT robertmoore ngsanalysisconfirmscommonitp53iandirb1imutationsandsuggestsimyciamplificationinocularadnexalsebaceouscarcinomas
AT jessicalhicks ngsanalysisconfirmscommonitp53iandirb1imutationsandsuggestsimyciamplificationinocularadnexalsebaceouscarcinomas
AT lauraamorsberger ngsanalysisconfirmscommonitp53iandirb1imutationsandsuggestsimyciamplificationinocularadnexalsebaceouscarcinomas
AT angelomdemarzo ngsanalysisconfirmscommonitp53iandirb1imutationsandsuggestsimyciamplificationinocularadnexalsebaceouscarcinomas
AT yingzou ngsanalysisconfirmscommonitp53iandirb1imutationsandsuggestsimyciamplificationinocularadnexalsebaceouscarcinomas
AT charlesgeberhart ngsanalysisconfirmscommonitp53iandirb1imutationsandsuggestsimyciamplificationinocularadnexalsebaceouscarcinomas
AT ashleyacampbell ngsanalysisconfirmscommonitp53iandirb1imutationsandsuggestsimyciamplificationinocularadnexalsebaceouscarcinomas